Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study-Reference-Cited by-同舟云学术

Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study

Published:2019-03 Issue: Volume:209 Page:97-105
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Frigoli Enrico,Smits Pieter,Vranckx Pascal,Ozaki Yokio,Tijssen Jan,Jüni Peter,Morice Marie-Claude,Onuma Yoshinobu,Windecker Stephan,Frenk Andrè,Spaulding Christian,Chevalier Bernard,Barbato Emanuele,Tonino Pim,Hildick-Smith David,Roffi Marco,Kornowski Ran,Schultz Carl,Lesiak Maciej,Iñiguez Andrés,Colombo Antonio,Alasnag Mirvat,Mullasari Ajit,James Stefan,Stankovic Goran,Ong Paul J.L,Rodriguez Alfredo E,Mahfoud Felix,Bartunek Jozef,Moschovitis Aris,Laanmets Peep,Leonardi Sergio,Heg Dik,Sunnåker Mikael,Valgimigli Marco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom drug-coated stent vs. the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy;Stefanini;EuroIntervention,2016

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

3. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

4. Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates;Valgimigli;J Am Coll Cardiol,2015

5. Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial;European Journal of Internal Medicine;2024-08

2. Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 years;Open Heart;2024-06

3. Percutaneous Coronary Interventions Using a Ridaforolimus‐Eluting Stent in Patients at High Bleeding Risk;Journal of the American Heart Association;2024-01-16

4. Optimal time of dual antiplatelet therapy in patients with coronary heart disease (literature review);The Siberian Journal of Clinical and Experimental Medicine;2024-01-12

5. Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk;JAMA Cardiology;2024-01-01